Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Brechot C: Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol. 1992, 15: 382-386.
Article
CAS
PubMed
Google Scholar
Wang JT, Sheu JC, Lin JT, Wang TH, Chen DS: Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. J Infect Dis. 1992, 166: 1167-1169.
Article
CAS
PubMed
Google Scholar
Laskus T, Radkowski M, Piasek A, Nowicki M, Horban A, Cianciara J, Rakela J: Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis. 2000, 181: 442-448.
Article
CAS
PubMed
Google Scholar
Ferri C, Pileri S, Zignego AL: Hepatitis C virus, B-cell disorders, and non-Hodgkin's lymphoma. Infectious Causes of Cancer: Targets for Intervention. Edited by: Goedert JJ. 2000, Towota, NJ: Humana Press, Inc, 349-368.
Chapter
Google Scholar
Yokozaki S, Takamatsu J, Nakano I, Katano Y, Toyoda H, Hayashi K, Hayakawa T, Fukuda Y: Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy. Blood. 2000, 96: 4293-4299.
CAS
PubMed
Google Scholar
Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, De Moerloose P, White GC, Angiolillo AL, Luban NL, Sherman KE, Manco-Johnson M, Preiss L, Leissinger C, Kessler CM, Cohen AR, DiMichele D, Hilgartner MW, Aledort LM, Kroner BL, Rosenberg PS, Hatzakis A: End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood. 2002, 100: 1584-1589.
CAS
PubMed
Google Scholar
Goedert JJ, Hatzakis A, Sherman KE, Eyster ME: Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection. J Infect Dis. 2001, 184: 1202-1205.
Article
CAS
PubMed
Google Scholar
Taylor JM, Fahey JL, Detels R, Giorgi JV: CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr. 1989, 2: 114-124.
CAS
PubMed
Google Scholar
Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S: Binding of hepatitis C virus to CD81. Science. 1998, 282: 938-941.
Article
CAS
PubMed
Google Scholar
Morsica G, Tambussi G, Sitia G, Novati R, Lazzarin A, Lopalco L, Mukenge S: Replication of hepatitis C virus in B lymphocytes (CD19+). Blood. 1999, 94: 1138-1139.
CAS
PubMed
Google Scholar
Zehender G, Meroni L, De Maddalena C, Varchetta S, Monti G, Galli M: Detection of hepatitis C virus RNA in CD19 peripheral blood mononuclear cells of chronically infected patients. J Infect Dis. 1997, 176: 1209-1214.
Article
CAS
PubMed
Google Scholar
Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM, Lai MM: Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol. 2003, 77: 2134-2146.
Article
CAS
PubMed
PubMed Central
Google Scholar
Farci P, Shimoda A, Wong D, Cabe zon T, De Gioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter HJ, Purcell RH: Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A. 1996, 93: 15394-15399.
Article
CAS
PubMed
PubMed Central
Google Scholar
Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, Mosca M, Filliponi F, Brunetto RM, Bonino F, Abrignani S, Valiante NM: Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med. 2002, 195: 35-41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tseng CT, Klimpel GR: Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med. 2002, 195: 43-49.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chang KM, Thimme R, Melpolder JJ, Oldach D, Pemberton J, Moorhead-Loudis J, McHutchison JG, Alter HJ, Chisari FV: Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology. 2001, 33: 267-276.
Article
CAS
PubMed
Google Scholar
Rosen HR, Miner C, Sasaki AW, Lewinsohn DM, Conrad AJ, Bakke A, Bouwer HG, Hinrichs DJ: Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology. 2002, 35: 190-198.
Article
PubMed
Google Scholar